_________
false
כן-פייט ביופרמה בע"מ
2
379
CAN-FITE BIOPHARMA LTD
Corporation no:
512022153
4330
Israel Securities Authority
Tel Aviv Stock Exchange
C001
(
Public
)
Reported via MAGNA:
30/03/2023
www.isa.gov.il
www.tase.co.il
Reference:
2023-02-035433
Time of broadcast:
14:06
14:06
Report of Periodic or Interim Report
Regulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
Financial results for the year ended December 31, 2022
f20f2022_canfitebioEDGAR15_Bannerless_isa.pdf
Link to filing on foreign stock exchange (optional):
_________
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
-1
Date of revision of form structure:
21/02/2023
Address:
Bareket
10
,
Petach-Tikva
47190
,
Tel:
03-9241114
,
03-9213501
Fax:
03-9249378
E-mail address:
motti@canfite.co.il
Company site:
www.canfite.com
Previous names of reporting entity:
Name of the Signatory:
FISHMAN PNINA
Position of Signatory in the reporting corporation:
Director, CFO
Name of Employer Company:
Address:
BAR-ON
2
,
HERZLIA
4658084
Telephone:
03-9241114
Facsimile:
03-9249378
E-mail:
pnina@canfite.co.il
2